Evans B T, Pritchard C
Southampton University Trust Hospital, Southampton, UK.
Public Health. 2000 Sep;114(5):336-9. doi: 10.1016/s0033-3506(00)00359-0.
Health funding is central to public health planning and clinical practice, hence this comparison of GDP health expenditure and five year post-diagnostic cancer survival rates of England and Wales with the USA and eight European countries. The three lowest proportional GDP health expenditures over the period 1980-1990 were Denmark, England and Wales, and Spain. The USA had the highest proportional GDP expenditure, followed by France, Germany, and The Netherlands. Overall the USA had the best cancer survival rates in the 14 sites reviewed, followed by Switzerland, The Netherlands, and Germany. The least successful were Spain, England and Wales, and Italy. In respect to the high incidence cancers, colorectal, lung, and female breast cancers, England and Wales survival rates were the poorest of all ten countries, followed by Denmark and Spain. Higher GDP health expenditure and longer survival rates for each gender were significantly correlated indicating a possible association between fiscal input and clinical outcomes, which poses problems for the development of effective public health.
卫生资金对于公共卫生规划和临床实践至关重要，因此才有了将英格兰、威尔士与美国及八个欧洲国家的国内生产总值（GDP）卫生支出以及癌症诊断后五年生存率进行比较。1980年至1990年期间，国内生产总值卫生支出占比最低的三个国家是丹麦、英格兰和威尔士以及西班牙。美国的国内生产总值支出占比最高，其次是法国、德国和荷兰。总体而言，在所审查的14个部位中，美国的癌症生存率最高，其次是瑞士、荷兰和德国。效果最差的是西班牙、英格兰和威尔士以及意大利。就结直肠癌、肺癌和女性乳腺癌等高发病率癌症而言，英格兰和威尔士的生存率在所有十个国家中是最差的，其次是丹麦和西班牙。较高的国内生产总值卫生支出与各性别更长的生存率显著相关，这表明财政投入与临床结果之间可能存在关联，这给有效公共卫生的发展带来了问题。
